Monday, 8 May 2017 to Tuesday, 9 May 2017 | Milton Keynes
Combining lived experience, research, policy and practice.
Contrary to the dominant media narrative which sees drug “addiction” as the uniquely powerful disruptor of otherwise stable lives, the experience of the vast majority of drug users who need treatment is that they faced challenges with their mental health, the criminal justice system, poor educational outcomes, disrupted childhoods and insecure accommodation - before they became dependent. Rather than these problems being a consequence of their dependence, they are more likely to be a key part of the reason why an individual’s drug use became problematic in the first place.
As Public Health England’s recent Evidence Review has demonstrated, the English treatment system has much to be proud of, and stands comparison with the best in the world. However, PHE also acknowledges that failure to address the wider social disadvantage, which underpins dependence and inhibits recovery, is a continuing policy failure.
In recognition of this, Collective Voice has been working with the Home Office and PHE to ensure that the forthcoming drug strategy identifies a way to turn the rhetoric of its predecessors into meaningful action. In addition, Collective Voice has been active with colleagues in the homelessness, mental health and criminal justice sectors, as an associate member of the MEAM Coalition: seeking to influence policy on multiple disadvantage, and in particular, focusing on the 60,000 individuals who experience the most profound social disadvantage each year, most of whom have substance misuse problems.
In May, the MEAM partners are working with the Big Lottery Fund, Calouste Gulbenkian Foundation, Lankelly Chase and Revolving Doors Agency to bring together practitioners from across sectors for a two-day summit. The event will identify how we can collectively organise to better deliver integrated services, which make a real difference and gain political traction for multiple disadvantage. The event is called a “summit” to reflect the partners’ commitment to grassroots experience and expertise. Consistent with this there will be opportunity for participants to shape the programme. Fifty spaces have been set aside for the substance misuse sector to ensure that our perspective is fully reflected at the event, and in its outcomes.
The two-day event will be 8-9 May in Milton Keynes at a heavily subsidised cost of £200 per person, including meals and accommodation for two days, and a daily rate of £75. Notwithstanding the extreme pressure on budgets, participation in this event provides opportunity for the sector to contribute its unique perspective to a collective strategic attempt to address long-standing deficits in our treatment and recovery system. It would be a shame if the substance misuse sector failed to grasp this opportunity.
Paul Hayes is CEO of Collective Voice, which represents the drug and alcohol treatment sector to government and the public. Paul's previous roles include 25 years in the probation service and 13 years as CEO of the National Treatment Agency for Substance Misuse.
9 Feb 2017 - 4:18pm
9 Feb 2017 - 1:37pm
8 Feb 2017 - 1:32pm